Top Updates Back
Astellas Pharma s.r.o.
Japan
製品と疾患領域
Rx+事業創成
アステラス製品の入手可能性の向上
事業活動におけるサステナビリティ
事業開発
製品
東京
岡村
Company name
Group Parent Subsidiary Customer Supplier Alliance Bank Shareholder
武田テバ薬品株式会社
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
日医工株式会社
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
武田テバファーマ株式会社
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
Avara Norman Pharmaceutical Services, Inc.
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group
武田薬品工業株式会社
Group company Parent Subsidiary Customer Supplier Alliance Bank, lending and credit Investment, equity and shareholders
Group

8 entries
DateDescription
1894 1894年に設立された藤沢薬品工業。
1923 1923年に設立された山之内製薬。
1940 1940年に山之内製薬株式会社に改称。
1942 1942年に本社を東京へ移転。
2005-04 2005年4月に山之内製薬と藤沢薬品工業の合併によりアステラスが発足。
2005-04 Astellas was established in April 2005 through the merger of Yamanouchi Pharmaceutical (founded in 1923) and Fujisawa Pharmaceutical (founded in 1894). Leaders from Yamanouchi and Fujisawa shake hands, marking the 2005 merger that formed Astellas and shaped a patient-first global strategy.
2025-04 2025年4月にアステラス製薬が創立20周年を迎えた。
2025-04 In April 2025, Astellas celebrated our 20th Anniversary as a company.
+ Loaded when opened
✅
2026-09-21 18:04 (Model: ggml-org/gpt-oss-20b )
↑